Recognition and Management of Systemic Lupus Erythematosus

被引：0

作者：

Johann O. Schroeder

Hans H. Euler

机构：

[1] Christian Albrecht University of Kiel,Department of Internal Medicine and Rheumatology, Second Medical Department

[2] Medizinische Klinik der Christian-Albrecht Universität,undefined

来源：

Drugs | 1997年 / 54卷

关键词：

Systemic Lupus Erythematosus; Lupus Nephritis; Rheumatol; Hydroxychloroquine; Acitretin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Systemic lupus erythematosus (SLE) is an inflammatory systemic disease that causes organ damage by the deposition of autoantibodies and complement activating immune complexes or by vascular occlusion due to procoagulant states associated with antiphospholipid antibodies. The vast majority of cases occur in women of childbearing age. SLE is diagnosed on the basis of its clinical manifestations and the demonstration of characteristic immunological phenomena, especially anti-nuclear antibodies.

引用

页码：422 / 434

页数：12

共 50 条

[31] Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis [J].

Beckwith, Hannah ;

Lightstone, Liz .

NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4) :250-254

[32] Obstetrics complications of systemic lupus erythematosus and antiphospholipid syndrome: A multidisciplinary management [J].

Mattuizzi, A. ;

Madar, H. ;

Froeliger, A. ;

Houssin, C. ;

Chabanier, P. ;

Merlot, B. ;

Lazaro, E. ;

Elleboode, B. ;

Sentilhes, L. .

GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2020, 48 (05) :448-452

[33] The enigma of antigen selection and antigen recognition in systemic lupus erythematosus [J].

Mevorach, D ;

Naparstek, Y .

ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (11) :841-842

[34] Management of Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus [J].

Mary-Clair Yelovich ;

Kimberly J. Legault .

Current Treatment Options in Rheumatology, 2019, 5 :190-200

[35] Management of dyslipidemia in children and adolescents with systemic lupus erythematosus [J].

Ardoin, S. P. ;

Sandborg, C. ;

Schanberg, L. E. .

LUPUS, 2007, 16 (08) :618-626

[36] Management of Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus [J].

Yelovich, Mary-Clair ;

Legault, Kimberly J. .

CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2019, 5 (03) :190-200

[37] An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus [J].

Thakral A. ;

Klein-Gitelman M.S. .

Rheumatology and Therapy, 2016, 3 (2) :209-219

[38] Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus [J].

Yong, P. F. K. ;

Aslam, L. ;

Karim, M. Y. ;

Khamashta, M. A. .

RHEUMATOLOGY, 2008, 47 (09) :1400-1405

[39] Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New [J].

Basta, Fabio ;

Fasola, Federica ;

Triantafyllias, Konstantinos ;

Schwarting, Andreas .

RHEUMATOLOGY AND THERAPY, 2020, 7 (03) :433-446

[40] Prediction and management of cardiovascular outcomes in systemic lupus erythematosus [J].

Frostegard, Johan .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) :247-253

← 1 2 3 4 5 →